DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
LERDELIMUMAB
3
Antibody
Investigational
Unknown
Unknown
Unknown
Transforming growth factor beta-2 inhibitor
LERDELIMUMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
GX1FEU3QSM
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETRIPAMIL
3
Small molecule
Investigational
Unknown
Unknown
Atrial Fibrillation; Tachycardia, Ventricular
Unknown
ETRIPAMIL
×
Maximum Phase:
3
First Approval:
None
UNII:
S82A18Y42P
Molecule Type:
Small molecule
Molecular Formula:
C27H36N2O4
Molecular Weight:
452.6
AlogP:
4.86
PSA:
71.79
HBD:
0.0
HBA:
#RotB:
12.0
Source:
NOLATREXED
3
Small molecule
Investigational
Unknown
Unknown
Liver Neoplasms
Thymidylate synthase antagonist
NOLATREXED
×
Maximum Phase:
3
First Approval:
None
UNII:
K75ZUN743Q
Molecule Type:
Small molecule
Molecular Formula:
C14H12N4OS
Molecular Weight:
284.34
AlogP:
2.36
PSA:
84.66
HBD:
2.0
HBA:
#RotB:
2.0
Source:
IMIDAPRIL
3
Small molecule
Investigational
Unknown
Unknown
Polycystic Kidney, Autosomal Dominant; Essential Hypertension; Cardiovascular Diseases
Angiotensin-converting enzyme inhibitor
IMIDAPRIL
×
Maximum Phase:
3
First Approval:
None
UNII:
BW7H1TJS22
Molecule Type:
Small molecule
Molecular Formula:
C20H27N3O6
Molecular Weight:
405.45
AlogP:
0.88
PSA:
116.25
HBD:
2.0
HBA:
#RotB:
9.0
Source:
AMIBEGRON HYDROCHLORIDE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Beta-3 adrenergic receptor agonist
AMIBEGRON HYDROCHLORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
N910CJ679E
Molecule Type:
Small molecule
Molecular Formula:
C22H27Cl2NO4
Molecular Weight:
440.37
AlogP:
3.46
PSA:
67.79
HBD:
2.0
HBA:
#RotB:
8.0
Source:
FULRANUMAB
3
Antibody
Investigational
Unknown
Unknown
Chronic Pain; Diabetic Neuropathies; Low Back Pain; Pain; Osteoarthritis
Beta-nerve growth factor inhibitor
FULRANUMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
0E986JU40I
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAK-536
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TAK-536
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
APRICITABINE
3
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
APRICITABINE
×
Maximum Phase:
3
First Approval:
None
UNII:
K1YX059ML1
Molecule Type:
Small molecule
Molecular Formula:
C8H11N3O3S
Molecular Weight:
229.26
AlogP:
-0.59
PSA:
90.37
HBD:
2.0
HBA:
#RotB:
2.0
Source:
EVACETRAPIB
3
Small molecule
Investigational
Unknown
Unknown
Lipid Metabolism Disorders; Cardiovascular Diseases; Hypercholesterolemia; Hyperlipidemias
Cholesteryl ester transfer protein inhibitor
EVACETRAPIB
×
Maximum Phase:
3
First Approval:
None
UNII:
51XWV9K850
Molecule Type:
Small molecule
Molecular Formula:
C31H36F6N6O2
Molecular Weight:
638.66
AlogP:
7.1
PSA:
87.38
HBD:
1.0
HBA:
#RotB:
7.0
Source:
DABIGATRAN
3
Small molecule
Investigational
Unknown
Unknown
Ischemic Stroke; Renal Insufficiency; Respiratory Syncytial Virus Infections; CADASIL; Hemorrhage; Atrial Fibrillation; Hematoma; Stroke; Thromboembolism; Venous Thromboembolism; Wounds and Injuries
Thrombin inhibitor
DABIGATRAN
×
Maximum Phase:
3
First Approval:
None
UNII:
I0VM4M70GC
Molecule Type:
Small molecule
Molecular Formula:
C25H25N7O3
Molecular Weight:
471.52
AlogP:
2.99
PSA:
150.22
HBD:
4.0
HBA:
#RotB:
9.0
Source:
ONO-1101
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ONO-1101
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OXYCODEGOL
3
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis, Knee; Chronic Pain; Low Back Pain
Mu opioid receptor agonist
OXYCODEGOL
×
Maximum Phase:
3
First Approval:
None
UNII:
J2WIV0JMML
Molecule Type:
Small molecule
Molecular Formula:
C31H49NO10
Molecular Weight:
595.73
AlogP:
1.59
PSA:
106.54
HBD:
1.0
HBA:
#RotB:
20.0
Source:
BROTIZOLAM
3
Small molecule
Investigational
Unknown
Unknown
Anxiety; Dementia; Depressive Disorder; Schizophrenia; Sleep Initiation and Maintenance Disorders
Unknown
BROTIZOLAM
×
Maximum Phase:
3
First Approval:
None
UNII:
5XZM1R3DKF
Molecule Type:
Small molecule
Molecular Formula:
C15H10BrClN4S
Molecular Weight:
393.7
AlogP:
4.4
PSA:
43.07
HBD:
0.0
HBA:
#RotB:
1.0
Source:
SILVER DIAMMINE FLUORIDE
3
Small molecule
Investigational
Unknown
Unknown
Gingivitis; Dental Caries
Unknown
SILVER DIAMMINE FLUORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
DDU19UEV1Y
Molecule Type:
Small molecule
Molecular Formula:
AgF
Molecular Weight:
126.87
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MITOMYCINS
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
MITOMYCINS
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
APADENOSON
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A2a receptor agonist
APADENOSON
×
Maximum Phase:
3
First Approval:
None
UNII:
BTS1Y6777M
Molecule Type:
Small molecule
Molecular Formula:
C23H30N6O6
Molecular Weight:
486.53
AlogP:
-0.12
PSA:
174.71
HBD:
4.0
HBA:
#RotB:
5.0
Source:
ABIVERTINIB
3
Small molecule
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome; Carcinoma, Non-Small-Cell Lung
Epidermal growth factor receptor erbB1 inhibitor
ABIVERTINIB
×
Maximum Phase:
3
First Approval:
None
UNII:
CER0OPG92L
Molecule Type:
Small molecule
Molecular Formula:
C26H26FN7O2
Molecular Weight:
487.54
AlogP:
4.51
PSA:
98.41
HBD:
3.0
HBA:
#RotB:
7.0
Source:
AK-105
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AK-105
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SETIPIPRANT
3
Small molecule
Investigational
Unknown
Unknown
Alopecia; Asthma; Rhinitis, Allergic, Seasonal
G protein-coupled receptor 44 antagonist
SETIPIPRANT
×
Maximum Phase:
3
First Approval:
None
UNII:
BHF20LA2GM
Molecule Type:
Small molecule
Molecular Formula:
C24H19FN2O3
Molecular Weight:
402.43
AlogP:
4.22
PSA:
62.54
HBD:
1.0
HBA:
#RotB:
3.0
Source:
DIAPEP-277
3
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1
Unknown
DIAPEP-277
×
Maximum Phase:
3
First Approval:
None
UNII:
F8778UWB0A
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SIVELESTAT SODIUM
3
Small molecule
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
SIVELESTAT SODIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
737RR8Y409
Molecule Type:
Small molecule
Molecular Formula:
C20H29N2NaO11S
Molecular Weight:
528.51
AlogP:
2.25
PSA:
138.87
HBD:
3.0
HBA:
#RotB:
7.0
Source:
OTILONIUM BROMIDE
3
Small molecule
Investigational
Unknown
Unknown
Digestive System Diseases
Unknown
OTILONIUM BROMIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
21HN3N72PV
Molecule Type:
Small molecule
Molecular Formula:
C29H43BrN2O4
Molecular Weight:
563.58
AlogP:
6.32
PSA:
64.63
HBD:
1.0
HBA:
#RotB:
16.0
Source:
CARBOPLATINE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CARBOPLATINE
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SERELAXIN
3
Protein
Investigational
Unknown
Unknown
Liver Diseases; Renal Insufficiency, Chronic; Coronary Disease; Pre-Eclampsia; Cardiovascular Diseases; Heart Failure
Relaxin receptor 1 activator
SERELAXIN
×
Maximum Phase:
3
First Approval:
None
UNII:
W0122B976Y
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FERROGLYCINE SULFATE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FERROGLYCINE SULFATE
×
Maximum Phase:
3
First Approval:
None
UNII:
JGK960078D
Molecule Type:
Small molecule
Molecular Formula:
C2H5FeNO6S
Molecular Weight:
226.97
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TECHNEGAS
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TECHNEGAS
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REXLEMESTROCEL-L
3
Cell
Investigational
Unknown
Unknown
Hypoplastic Left Heart Syndrome; Intervertebral Disc Degeneration
Unknown
REXLEMESTROCEL-L
×
Maximum Phase:
3
First Approval:
None
UNII:
4LS0IJZ59V
Molecule Type:
Cell
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MODUFOLIN
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MODUFOLIN
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LENZILUMAB
3
Antibody
Investigational
Unknown
Unknown
Leukemia, Myelomonocytic, Chronic; Lymphoma, Follicular; Arthritis, Rheumatoid; Asthma; Pneumonia; Severe Acute Respiratory Syndrome
Granulocyte-macrophage colony-stimulating factor inhibitor
LENZILUMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
IE4X6497XK
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PORFIROMYCIN
3
Small molecule
Investigational
Unknown
Unknown
Carcinoma; Head and Neck Neoplasms
Unknown
PORFIROMYCIN
×
Maximum Phase:
3
First Approval:
None
UNII:
H1WK901OA6
Molecule Type:
Small molecule
Molecular Formula:
C16H20N4O5
Molecular Weight:
348.36
AlogP:
-1.31
PSA:
127.96
HBD:
2.0
HBA:
#RotB:
3.0
Source:
GAVILIMOMAB
3
Antibody
Investigational
Unknown
Unknown
Graft vs Host Disease
Basigin other
GAVILIMOMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
TCR92293RC
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLYCOCHOLIC ACID
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GLYCOCHOLIC ACID
×
Maximum Phase:
3
First Approval:
None
UNII:
G59NX3I3RT
Molecule Type:
Small molecule
Molecular Formula:
C26H43NO6
Molecular Weight:
465.63
AlogP:
2.56
PSA:
127.09
HBD:
5.0
HBA:
#RotB:
6.0
Source:
PYRITINOL
3
Small molecule
Investigational
Unknown
Unknown
Anxiety; Attention Deficit Disorder with Hyperactivity; Dementia; Depressive Disorder; Schizophrenia
Unknown
PYRITINOL
×
Maximum Phase:
3
First Approval:
None
UNII:
AK5Q5FZH2R
Molecule Type:
Small molecule
Molecular Formula:
C16H20N2O4S2
Molecular Weight:
368.48
AlogP:
2.57
PSA:
106.7
HBD:
4.0
HBA:
#RotB:
7.0
Source:
IDECABTAGENE VICLEUCEL
3
Gene
Investigational
Unknown
Unknown
Multiple Myeloma
Tumor necrosis factor receptor superfamily member 17 binding agent
IDECABTAGENE VICLEUCEL
×
Maximum Phase:
3
First Approval:
None
UNII:
8PX1X7UG4D
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IDRAPARINUX
3
Oligosaccharide
Investigational
Unknown
Unknown
Unknown
Unknown
IDRAPARINUX
×
Maximum Phase:
3
First Approval:
None
UNII:
6ADD3H8MFZ
Molecule Type:
Oligosaccharide
Molecular Formula:
C38H64O49S7
Molecular Weight:
1529.35
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
1
2
…
221
222
223
224
225
226
227
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA